Featured Event Estado de las tecnologías disruptivas en el sector biotecnológico Madrid España Del 14/11/2022 11:30 to 14/11/2022 12:30 Access to innovation
New Approach to Glycovaccines 18/12/2024 Healthcare Access to innovation Innovative drugs IQS researchers are designing a new generation of glyconanoparticles functionalized with α-mannose to produce new, more... Partners - IQS
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market 18/12/2024 Healthcare Access to innovation Drug discovery Analysis projects 21% annual growth, with global sales expected to reach $39 billion by 2030. Partners - Alira Health
8TH ANNUAL NEUROSCIENCE INNOVATION FORUM FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT San Francisco United States Del 12/01/2025 to 12/01/2025 Healthcare Access to innovation International
Advanced Therapies Congress 2025 London United Kingdom Del 18/03/2025 to 19/03/2025 Healthcare Access to innovation International
GENESIS Biomed sponsors the 3rd Conference on Healthcare Entrepreneurship at the Gregorio... 28/11/2024 Healthcare Access to innovation The conference highlighted the importance of planning funding to ensure the survival of spin-offs and the development of... Partners - GENESIS Biomed
BCN HEALTH publishes a study evaluating the relationship between kidney failure, heart dis... 25/11/2024 Healthcare Access to innovation BCN HEALTH has published the study ‘Relationship between a diagnosis of kidney failure and heart diseases in patients... Partners - BCN Health
LeishGen: Advanced Genomic Platforms for Drug Resistance Biomarkers in Leishmania infantum 20/11/2024 Healthcare Access to innovation Antibiotic resistance LeishGenApp and LeishGenR are Nano1Health’s cutting-edge solutions for detecting drug resistance biomarkers in... Partners - Nano1Health SL
The data revolution and AI in the Health sector 14/11/2024 Healthcare Access to innovation The data and artificial intelligence revolution is driving deep changes in medical research. Partners - GENESIS Biomed
The Fight Against Pneumonia and Antibiotic Resistance: Vaxdyn and the K-Vax Vaccine Candid... 11/11/2024 Healthcare Access to innovation Innovative drugs On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K... Partners
